Activation of sGC has been shown to be beneficial in multiple pathological conditions and small molecule activators/stimulators of this pathway are currently being used in the clinic to treat patients with pulmonary hypertension (Ghofrani & Grimminger, 2009). The gene discussed is SGCB; the disease is pulmonary hypertension.